SNOMED CT-AU and Australian Medicines Terminology September 2020 Release

The National Clinical Terminology Service (NCTS) is pleased to announce that the September combined release of SNOMED CT®-AU1 and the Australian Medicines Terminology (AMT) is now available to registered users from the NCTS website.

Important Information

Third party reference sets

List of Medicines for Brand Consideration reference set

Produced by the Australian Government Department of Health, this reference set enables software vendors to identify AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) under The National Health (Pharmaceutical Benefits) Amendment (Active ingredient Prescribing) Regulations 2019 and The Veterans’ Affairs Pharmaceutical Benefits Schemes (Electronic Prescriptions and Active Ingredient Prescribing) Amendment Instrument 2019.

Electronic Recording and Reporting of Controlled Drugs

The following reference sets have been expanded to include AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP). Only the refset content has been expanded with no change to the existing format and the word ‘trade’ has been removed from the refset name.

  • Schedule 8 medications;
  • South Australia reportable Schedule 4 medications;
  • Tasmania reportable Schedule 4 medications;
  • Victoria reportable Schedule 4 medications; and
  • Queensland Health QScript Schedule 4 monitored medicines

The full description of the above reference sets can be viewed by selecting it within Reference Sets from the ACCESS tab.

Document Library update

The following document has been added to the Document Library:

Please refer to the NCTS Document Library Release Note v2.23 in Recent Updates

/Public Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.